- ►annals.org [PDF] HW Eijkhout, JWM van der Meer, CGM … - Annals of internal medicine, 2001 - Am Coll Physicians Background: In patients with hypogammaglobulinemia, substi- tution with
immunoglobulin is the treatment of choice to reduce both frequency and severity
of bacterial infections. Even with treatment, however, infections still ... Cited by 117 - Related articles - BL Direct - All 7 versions
PJ Busse, S Razvi, C Cunningham-Rundles - The Journal of Allergy and Clinical Immunology, 2002 - Elsevier Background: Common variable immunodeficiency (CVID) is a primary immune disorder
characterized by antibody deficiency and a decrease in serum IgG and IgA, IgM,
or both levels at least 2 SDs below the mean for age and not attributed to ... Cited by 107 - Related articles - BL Direct - All 6 versions
CM Roifman, H Levison, EW Gelfand - The Lancet, 1987 - Elsevier In a randomised cross-over study 12 patients with antibody deficiency and
chronic lung disease received monthly infusions of either 0·6 g/kg or 0·2 g/kg
intravenous immunoglobulin for six months, and were then switched to the ... Cited by 166 - Related articles - All 5 versions
P Quartier, M Debré, J De Blic, R de … - The Journal of pediatrics, 1999 - Elsevier Before the era of immunoglobulin replacement therapy, patients with XLA had
early-onset, severe, and recurrent infections, mainly caused by encapsulated
bacteria. 2 , 3 and 11 Initially, replacement with intramuscular ... Cited by 116 - Related articles - BL Direct - All 8 versions
LR Pierce, N Jain - Transfusion Medicine Reviews, 2003 - Elsevier Although US immune globulin intravenous (human) (IGIV) products have been
regarded as safe, it is important to recognize that many of the controlled
clinical studies of IGIVs have been of modest size and have limited power ... Cited by 96 - Related articles - BL Direct - All 5 versions
CM Roifman, H Schroeder, M Berger, R … - International immunopharmacology, 2003 - Elsevier A novel method of large-scale chromatography has been developed to improve
recovery and purity of immunoglobulin G (IgG) from pooled plasma. The current
study compares safety, toxicity and efficacy of two intravenous ... Cited by 45 - Related articles - All 4 versions
HM Chapel, GP Spickett, D Ericson, W Engl, … - Journal of Clinical Immunology, 2000 - Springer To compare the efficacy of immunoglobulin replacement therapy given
intravenously versus subcutaneously to prevent infections in patients with
primary antibody deficiency syndromes, an interna- tional, multicenter, ... Cited by 106 - Related articles - BL Direct - All 3 versions
H Kessary-Shoham, Y Levy, Y Shoenfeld, M … - Journal of Autoimmunity, 1999 - Elsevier Enhanced erythrocyte sequestration is one of the very few major adverse effects
of intravenous immunoglobulin (IVIg). IVIg contains high molecular weight IgG
complexes ( 300 kDa) which, in the presence of serum, mimic immune ... Cited by 59 - Related articles - BL Direct - All 4 versions
AS Wolberg, RH Kon, DM Monroe, M Hoffman - American journal of hematology, 2000 - interscience.wiley.com A small number of thromboembolic events, including deep venous thrombosis and
myocardial infarction, have been reported in patients receiving IVIG. These
events have primarily occurred in patients receiving high-dose IVIG and ... Cited by 86 - Related articles - BL Direct - All 3 versions
AJ Ammann, RF Ashman, RH Buckley, WR … - Clinical Immunology and Immunopathology, 1982 - Elsevier A 2-year corssover study was performed in 34 patients with antibody-deficiency
disorders characterized by normal T-cell function. Each patients was treated for
1 year with either ISG or MISG and then treated for an additional year with ... Cited by 87 - Related articles - All 2 versions
